LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 30.64 | 17.25 | 2451 | 1887 | 1.2986 | 1.0787 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 32.61 | 17.25 | 2052 | 2136 | 0.9605 | 0.9884 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 32.61 | 17.25 | 2175 | 2136 | 1.0181 | 1.0052 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 32.61 | 17.25 | 1010 | 2136 | 0.4728 | 0.7957 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 32.61 | 17.25 | 2014 | 2136 | 0.9427 | 0.9831 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 32.61 | 17.25 | 1 | 2136 | 0.0005 | -0.3361 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 32.61 | 17.25 | 2828 | 2136 | 1.3237 | 1.0823 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 32.61 | 17.25 | 3 | 2136 | 0.0014 | -0.2225 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 32.61 | 17.25 | 2710 | 2136 | 1.2685 | 1.0696 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 34.57 | 17.25 | 2247 | 2523 | 0.8906 | 0.9680 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 34.57 | 17.25 | 2452 | 2523 | 0.9718 | 0.9921 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 34.57 | 17.25 | 1191 | 2523 | 0.4720 | 0.8018 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 34.57 | 17.25 | 2210 | 2523 | 0.8759 | 0.9635 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 34.57 | 17.25 | 1 | 2523 | 0.0004 | -0.3270 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 34.57 | 17.25 | 3109 | 2523 | 1.2322 | 1.0589 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 34.57 | 17.25 | 1 | 2523 | 0.0004 | -0.3270 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 34.57 | 17.25 | 2964 | 2523 | 1.1747 | 1.0453 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.54 | 17.25 | 2460 | 2679 | 0.9180 | 0.9766 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.54 | 17.25 | 2650 | 2679 | 0.9889 | 0.9969 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.54 | 17.25 | 1469 | 2679 | 0.5482 | 0.8415 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.54 | 17.25 | 2375 | 2679 | 0.8863 | 0.9671 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.54 | 17.25 | 1 | 2679 | 0.0004 | -0.3238 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.54 | 17.25 | 3311 | 2679 | 1.2355 | 1.0590 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.54 | 17.25 | 1 | 2679 | 0.0004 | -0.3238 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 36.54 | 17.25 | 3148 | 2679 | 1.1747 | 1.0447 | MN20160310_N02 | H15 |